Global Rx-360 Consortium Aims To Curb Pharmaceutical Supply Chain Threats
This article was originally published in PharmAsia News
Executive Summary
Drug manufacturers are forming a consortium called Rx-360 to take the lead in protecting the global pharmaceutical supply chain from threats like the heparin adulterant potentially linked to deaths of 146 U.S. patients last year